CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results